Glomerulonephritis, Membranoproliferative
2 clinical trials · Condition
◉ Watch Glomerulonephritis, Membranoproliferative
| Record | Firm | Date |
|---|---|---|
| Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis (NCT00275613) | Mayo Clinic | 2005-11-01 |
| BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis (NCT00001789) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 1999-06-01 |
Track Glomerulonephritis, Membranoproliferative automatically
Every clearance here is in the API, with alerts when new ones post.